Barry Labinger, EVP, Biosciences Div. at Emergent Biosolutions, holds 25.18K shares in Emergent Biosolutions (Ticker: EBS), holds ― shares in Checkmate Pharmaceuticals (Ticker: CMPI). Most recently, Barry Labinger Sold ― shares of Emergent Biosolutions on Nov 17, 2015 for an estimated value of 123.22K.